ANXA1_HUMAN - dbPTM
ANXA1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ANXA1_HUMAN
UniProt AC P04083
Protein Name Annexin A1
Gene Name ANXA1
Organism Homo sapiens (Human).
Sequence Length 346
Subcellular Localization Nucleus . Cytoplasm . Cell projection, cilium . Cell membrane . Membrane
Peripheral membrane protein . Endosome membrane
Peripheral membrane protein . Basolateral cell membrane . Apical cell membrane . Lateral cell membrane . Secreted . Secreted, extr
Protein Description Plays important roles in the innate immune response as effector of glucocorticoid-mediated responses and regulator of the inflammatory process. Has anti-inflammatory activity. [PubMed: 8425544 Plays a role in glucocorticoid-mediated down-regulation of the early phase of the inflammatory response (By similarity Promotes resolution of inflammation and wound healing]
Protein Sequence MAMVSEFLKQAWFIENEEQEYVQTVKSSKGGPGSAVSPYPTFNPSSDVAALHKAIMVKGVDEATIIDILTKRNNAQRQQIKAAYLQETGKPLDETLKKALTGHLEEVVLALLKTPAQFDADELRAAMKGLGTDEDTLIEILASRTNKEIRDINRVYREELKRDLAKDITSDTSGDFRNALLSLAKGDRSEDFGVNEDLADSDARALYEAGERRKGTDVNVFNTILTTRSYPQLRRVFQKYTKYSKHDMNKVLDLELKGDIEKCLTAIVKCATSKPAFFAEKLHQAMKGVGTRHKALIRIMVSRSEIDMNDIKAFYQKMYGISLCQAILDETKGDYEKILVALCGGN
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAMVSEFLK
------CCHHHHHHH
13.693303336
3Sulfoxidation-----MAMVSEFLKQ
-----CCHHHHHHHH
3.0928465586
5Phosphorylation---MAMVSEFLKQAW
---CCHHHHHHHHHH
15.0026846344
21PhosphorylationIENEEQEYVQTVKSS
CCCCHHHHHHHHHHC
9.5020007894
24PhosphorylationEEQEYVQTVKSSKGG
CHHHHHHHHHHCCCC
21.6228796482
26UbiquitinationQEYVQTVKSSKGGPG
HHHHHHHHHCCCCCC
53.0221906983
27PhosphorylationEYVQTVKSSKGGPGS
HHHHHHHHCCCCCCC
32.7119625660
28PhosphorylationYVQTVKSSKGGPGSA
HHHHHHHCCCCCCCC
29.601956339
29UbiquitinationVQTVKSSKGGPGSAV
HHHHHHCCCCCCCCC
74.99-
29MalonylationVQTVKSSKGGPGSAV
HHHHHHCCCCCCCCC
74.9926320211
29AcetylationVQTVKSSKGGPGSAV
HHHHHHCCCCCCCCC
74.9926051181
34PhosphorylationSSKGGPGSAVSPYPT
HCCCCCCCCCCCCCC
28.7330266825
37PhosphorylationGGPGSAVSPYPTFNP
CCCCCCCCCCCCCCC
20.5922167270
37O-linked_GlycosylationGGPGSAVSPYPTFNP
CCCCCCCCCCCCCCC
20.596357859
39PhosphorylationPGSAVSPYPTFNPSS
CCCCCCCCCCCCCCC
13.8530266825
41PhosphorylationSAVSPYPTFNPSSDV
CCCCCCCCCCCCCHH
30.1530266825
41O-linked_GlycosylationSAVSPYPTFNPSSDV
CCCCCCCCCCCCCHH
30.15OGP
45PhosphorylationPYPTFNPSSDVAALH
CCCCCCCCCHHHHHH
40.0325159151
46PhosphorylationYPTFNPSSDVAALHK
CCCCCCCCHHHHHHH
37.0425159151
53AcetylationSDVAALHKAIMVKGV
CHHHHHHHHHHCCCC
40.2223954790
53UbiquitinationSDVAALHKAIMVKGV
CHHHHHHHHHHCCCC
40.2221906983
58AcetylationLHKAIMVKGVDEATI
HHHHHHCCCCCHHHH
35.52-
58UbiquitinationLHKAIMVKGVDEATI
HHHHHHCCCCCHHHH
35.5221906983
64PhosphorylationVKGVDEATIIDILTK
CCCCCHHHHHHHHHH
19.2046164621
70PhosphorylationATIIDILTKRNNAQR
HHHHHHHHHCCHHHH
28.4346164627
71AcetylationTIIDILTKRNNAQRQ
HHHHHHHHCCHHHHH
50.0823236377
71UbiquitinationTIIDILTKRNNAQRQ
HHHHHHHHCCHHHHH
50.0821906983
81UbiquitinationNAQRQQIKAAYLQET
HHHHHHHHHHHHHHH
23.7221906983
84PhosphorylationRQQIKAAYLQETGKP
HHHHHHHHHHHHCCC
17.4928152594
88PhosphorylationKAAYLQETGKPLDET
HHHHHHHHCCCHHHH
37.2328152594
90AcetylationAYLQETGKPLDETLK
HHHHHHCCCHHHHHH
50.2323954790
90UbiquitinationAYLQETGKPLDETLK
HHHHHHCCCHHHHHH
50.23906983
90MalonylationAYLQETGKPLDETLK
HHHHHHCCCHHHHHH
50.2326320211
95PhosphorylationTGKPLDETLKKALTG
HCCCHHHHHHHHHCC
43.4772261247
97AcetylationKPLDETLKKALTGHL
CCHHHHHHHHHCCCH
43.3423954790
97UbiquitinationKPLDETLKKALTGHL
CCHHHHHHHHHCCCH
43.34-
97MalonylationKPLDETLKKALTGHL
CCHHHHHHHHHCCCH
43.3426320211
98AcetylationPLDETLKKALTGHLE
CHHHHHHHHHCCCHH
52.3019814793
98UbiquitinationPLDETLKKALTGHLE
CHHHHHHHHHCCCHH
52.3021906983
101PhosphorylationETLKKALTGHLEEVV
HHHHHHHCCCHHHHH
27.67101661403
113UbiquitinationEVVLALLKTPAQFDA
HHHHHHHHCHHHCCH
54.00-
114PhosphorylationVVLALLKTPAQFDAD
HHHHHHHCHHHCCHH
24.6721815630
128UbiquitinationDELRAAMKGLGTDED
HHHHHHHHCCCCCHH
46.3821906983
128AcetylationDELRAAMKGLGTDED
HHHHHHHHCCCCCHH
46.3826051181
132PhosphorylationAAMKGLGTDEDTLIE
HHHHCCCCCHHHHHH
41.0622617229
136PhosphorylationGLGTDEDTLIEILAS
CCCCCHHHHHHHHHH
27.8227422710
143PhosphorylationTLIEILASRTNKEIR
HHHHHHHHCCCHHHH
35.8763722251
156PhosphorylationIRDINRVYREELKRD
HHHHHHHHHHHHHHH
14.7428152594
161AcetylationRVYREELKRDLAKDI
HHHHHHHHHHHHHHC
47.3319608861
161UbiquitinationRVYREELKRDLAKDI
HHHHHHHHHHHHHHC
47.3319608861
166AcetylationELKRDLAKDITSDTS
HHHHHHHHHCCCCCC
57.8923954790
166UbiquitinationELKRDLAKDITSDTS
HHHHHHHHHCCCCCC
57.8921890473
166MalonylationELKRDLAKDITSDTS
HHHHHHHHHCCCCCC
57.8926320211
169PhosphorylationRDLAKDITSDTSGDF
HHHHHHCCCCCCHHH
30.5929255136
170PhosphorylationDLAKDITSDTSGDFR
HHHHHCCCCCCHHHH
38.9429255136
172PhosphorylationAKDITSDTSGDFRNA
HHHCCCCCCHHHHHH
34.0829255136
173PhosphorylationKDITSDTSGDFRNAL
HHCCCCCCHHHHHHH
41.1629255136
182PhosphorylationDFRNALLSLAKGDRS
HHHHHHHHHHCCCCC
27.4223403867
185AcetylationNALLSLAKGDRSEDF
HHHHHHHCCCCCCCC
67.6423954790
185UbiquitinationNALLSLAKGDRSEDF
HHHHHHHCCCCCCCC
67.6421906983
185MalonylationNALLSLAKGDRSEDF
HHHHHHHCCCCCCCC
67.6426320211
189PhosphorylationSLAKGDRSEDFGVNE
HHHCCCCCCCCCCCH
46.3827050516
201PhosphorylationVNEDLADSDARALYE
CCHHHCHHHHHHHHH
27.8030624053
207PhosphorylationDSDARALYEAGERRK
HHHHHHHHHHHHHCC
11.6227273156
214SumoylationYEAGERRKGTDVNVF
HHHHHHCCCCCCCCC
72.83-
214UbiquitinationYEAGERRKGTDVNVF
HHHHHHCCCCCCCCC
72.8321906983
214SumoylationYEAGERRKGTDVNVF
HHHHHHCCCCCCCCC
72.8328112733
216PhosphorylationAGERRKGTDVNVFNT
HHHHCCCCCCCCCCH
39.5520873877
223PhosphorylationTDVNVFNTILTTRSY
CCCCCCCHHHHCCCH
13.1027050516
226PhosphorylationNVFNTILTTRSYPQL
CCCCHHHHCCCHHHH
19.1346164615
230PhosphorylationTILTTRSYPQLRRVF
HHHHCCCHHHHHHHH
7.5422817900
239AcetylationQLRRVFQKYTKYSKH
HHHHHHHHHHCCCCC
43.3419608861
239UbiquitinationQLRRVFQKYTKYSKH
HHHHHHHHHHCCCCC
43.3419608861
240PhosphorylationLRRVFQKYTKYSKHD
HHHHHHHHHCCCCCC
9.5522817900
242AcetylationRVFQKYTKYSKHDMN
HHHHHHHCCCCCCHH
44.4226051181
243PhosphorylationVFQKYTKYSKHDMNK
HHHHHHCCCCCCHHH
18.3628258704
244PhosphorylationFQKYTKYSKHDMNKV
HHHHHCCCCCCHHHH
25.6828258704
245AcetylationQKYTKYSKHDMNKVL
HHHHCCCCCCHHHHH
40.3025825284
250AcetylationYSKHDMNKVLDLELK
CCCCCHHHHHCEEEC
37.2225825284
250UbiquitinationYSKHDMNKVLDLELK
CCCCCHHHHHCEEEC
37.2219608861
257UbiquitinationKVLDLELKGDIEKCL
HHHCEEECCCHHHHH
45.2021906983
257AcetylationKVLDLELKGDIEKCL
HHHCEEECCCHHHHH
45.2026051181
263S-palmitoylationLKGDIEKCLTAIVKC
ECCCHHHHHHHHHHH
2.3729575903
269AcetylationKCLTAIVKCATSKPA
HHHHHHHHHHHCCHH
16.4326051181
274MethylationIVKCATSKPAFFAEK
HHHHHHCCHHHHHHH
35.69-
274UbiquitinationIVKCATSKPAFFAEK
HHHHHHCCHHHHHHH
35.69-
274AcetylationIVKCATSKPAFFAEK
HHHHHHCCHHHHHHH
35.6925953088
281MethylationKPAFFAEKLHQAMKG
CHHHHHHHHHHHHCC
48.0819608861
281AcetylationKPAFFAEKLHQAMKG
CHHHHHHHHHHHHCC
48.0825825284
281UbiquitinationKPAFFAEKLHQAMKG
CHHHHHHHHHHHHCC
48.0819608861
287UbiquitinationEKLHQAMKGVGTRHK
HHHHHHHCCCCHHHH
54.1621906983
287AcetylationEKLHQAMKGVGTRHK
HHHHHHHCCCCHHHH
54.1625953088
294AcetylationKGVGTRHKALIRIMV
CCCCHHHHHHHHHHH
41.4125825284
302PhosphorylationALIRIMVSRSEIDMN
HHHHHHHCCCCCCHH
16.8322468782
308SulfoxidationVSRSEIDMNDIKAFY
HCCCCCCHHHHHHHH
6.2830846556
312AcetylationEIDMNDIKAFYQKMY
CCCHHHHHHHHHHHH
34.9919608861
312UbiquitinationEIDMNDIKAFYQKMY
CCCHHHHHHHHHHHH
34.9919608861
312SumoylationEIDMNDIKAFYQKMY
CCCHHHHHHHHHHHH
34.9919608861
312MalonylationEIDMNDIKAFYQKMY
CCCHHHHHHHHHHHH
34.9926320211
317UbiquitinationDIKAFYQKMYGISLC
HHHHHHHHHHHHHHH
23.78-
318SulfoxidationIKAFYQKMYGISLCQ
HHHHHHHHHHHHHHH
1.8728465586
319PhosphorylationKAFYQKMYGISLCQA
HHHHHHHHHHHHHHH
20.5328152594
322PhosphorylationYQKMYGISLCQAILD
HHHHHHHHHHHHHHH
20.8028152594
324S-nitrosocysteineKMYGISLCQAILDET
HHHHHHHHHHHHHHC
1.73-
324S-nitrosylationKMYGISLCQAILDET
HHHHHHHHHHHHHHC
1.7322178444
332UbiquitinationQAILDETKGDYEKIL
HHHHHHCCCCHHHHH
47.97-
332SumoylationQAILDETKGDYEKIL
HHHHHHCCCCHHHHH
47.9725114211
335PhosphorylationLDETKGDYEKILVAL
HHHCCCCHHHHHHHH
27.9946164633
337UbiquitinationETKGDYEKILVALCG
HCCCCHHHHHHHHCC
34.80-
343S-nitrosocysteineEKILVALCGGN----
HHHHHHHCCCC----
4.77-
343S-nitrosylationEKILVALCGGN----
HHHHHHHCCCC----
4.7722178444
343S-palmitoylationEKILVALCGGN----
HHHHHHHCCCC----
4.7729575903

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
5SPhosphorylationKinaseCHAK1Q96QT4
PSP
21YPhosphorylationKinaseEGFRP00533
Uniprot
21YPhosphorylationKinaseSRC64-PhosphoELM
21YPhosphorylationKinaseABL-FAMILY-GPS
21YPhosphorylationKinaseSRCP12931
PSP
21YPhosphorylationKinaseABL1P00519
PhosphoELM
24TPhosphorylationKinasePKC-FAMILY-GPS
24TPhosphorylationKinasePKC_GROUP-PhosphoELM
27SPhosphorylationKinasePRKCAP17252
GPS
27SPhosphorylationKinasePKC-FAMILY-GPS
27SPhosphorylationKinasePKC-Uniprot
27SPhosphorylationKinasePKC_GROUP-PhosphoELM
28SPhosphorylationKinasePRKCAP17252
GPS
28SPhosphorylationKinasePRKCBP05771
GPS
28SPhosphorylationKinasePKC-FAMILY-GPS
28SPhosphorylationKinasePKC_GROUP-PhosphoELM
216TPhosphorylationKinasePRKG1Q13976
GPS
216TPhosphorylationKinasePRKACAP17612
GPS
216TPhosphorylationKinasePKA-FAMILY-GPS
216TPhosphorylationKinasePKA_GROUP-PhosphoELM
-KUbiquitinationE3 ubiquitin ligaseUBE3AQ05086
PMID:19204938

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of ANXA1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ANXA1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
S10AB_HUMANS100A11physical
8557678
K2C8_HUMANKRT8physical
9459484
UBE3A_HUMANUBE3Aphysical
19204938
G3P_HUMANGAPDHphysical
21900206
KLH23_HUMANKLHL23physical
21900206
APBB1_HUMANAPBB1physical
21900206
CSAD_HUMANCSADphysical
21900206
CA123_HUMANC1orf123physical
21900206
RFA1_HUMANRPA1physical
21900206
U119A_HUMANUNC119physical
21900206
OTUB1_HUMANOTUB1physical
21900206
ERG28_HUMANC14orf1physical
21900206
XRCC6_HUMANXRCC6physical
21900206
KMT2B_HUMANKMT2Bphysical
21900206
TCPH_HUMANCCT7physical
21900206
UB2D1_HUMANUBE2D1physical
21900206
CSN6_HUMANCOPS6physical
21900206
LRIF1_HUMANLRIF1physical
21900206
FAF1_HUMANFAF1physical
21900206
ANXA1_HUMANANXA1genetic
12689596
ANXA5_HUMANANXA5physical
12689596
NEMO_HUMANIKBKGphysical
21383699
RIPK1_HUMANRIPK1physical
21383699
TF65_HUMANRELAphysical
21383699
ANXA4_HUMANANXA4physical
22939629
HMGA1_HUMANHMGA1physical
18850631
MEIS2_HUMANMEIS2physical
25416956
UBP7_HUMANUSP7physical
25695607
ACTS_HUMANACTA1physical
22773844
PA24A_HUMANPLA2G4Aphysical
17873281
S10AB_HUMANS100A11physical
17932043
PA24A_HUMANPLA2G4Aphysical
17932043

Drug and Disease Associations
Kegg Disease
H00006 Hairy-cell leukemia
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
DB00288Amcinonide
DB01234Dexamethasone
DB00741Hydrocortisone
Regulatory Network of ANXA1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Characterization by tandem mass spectrometry of structuralmodifications in proteins.";
Biemann K., Scoble H.A.;
Science 237:992-998(1987).
Cited for: ACETYLATION AT ALA-2, AND MASS SPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-161; LYS-239; LYS-250;LYS-281 AND LYS-312, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Phosphorylation of annexin I by TRPM7 channel-kinase.";
Dorovkov M.V., Ryazanov A.G.;
J. Biol. Chem. 279:50643-50646(2004).
Cited for: PHOSPHORYLATION AT SER-5 BY TRPM7.
"Location of sites in human lipocortin I that are phosphorylated byprotein tyrosine kinases and protein kinases A and C.";
Varticovski L., Chahwala S.B., Whitman M., Cantley L., Schindler D.,Chow E.P., Sinclair L.K., Pepinsky R.B.;
Biochemistry 27:3682-3690(1988).
Cited for: PARTIAL PROTEIN SEQUENCE, AND PHOSPHORYLATION AT TYR-21 BY EGFR ANDSER-27 BY PKC.
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells.";
Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.;
J. Proteome Res. 8:3852-3861(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-39 AND TYR-207, AND MASSSPECTROMETRY.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-39 AND TYR-207, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-21, AND MASSSPECTROMETRY.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-207, AND MASSSPECTROMETRY.

TOP